Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07298824 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Oct 1, 2025 to Dec 1, 2025
    • Study completion date: Jul 1, 2027 to Jul 30, 2027
    • Eligibility criteria expanded, about 202 words
    • Secondary endpoints: details revised at 14 of 14 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To investigate whether probiotic MR-61 can assist in slowing down the progression rate of myopia (a prospective randomized controlled study).
Trial Details
NCT Number NCT07298824
Lead Sponsor Second Affiliated Hospital of Nanchang University
Conditions
(from sponsor)		 Myopia Progressing
Related terms Myopia
Enrollment 164 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov